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Objectives. The purpose of the study was to evaluate the
cardiopulmonary exercise capacity and ventilatory function in
adults with atrial septal defect (ASD) preoperatively and 4
months and 10 years postoperatively.
Background. Only few data are available on cardiopulmonary
exercise tolerance after ASD closure, but detailed knowledge
might be helpful for indication for defect closure in certain
patients.
Methods. The study was performed in adult patients (mean
[6SD] age at operation 39.9 6 11.5 years; left–right shunt 9.6 6
5.6 liters/min; pulmonary/systemic flow ratio 2.8 6 1.2; mean
pulmonary artery pressure 18.2 6 6.2 mm Hg). Cardiopulmonary
exercise testing was performed with a bicycle ergometer. We
determined peak oxygen uptake, anaerobic threshold, perfor-
mance at anaerobic threshold and maximal performance in
relation to these variables in a normal group. Ventilatory function
at rest was expressed by vital capacity, maximal voluntary venti-
lation and forced expiratory volume in 1 s.
Results. Preoperatively, ventilatory function at rest was only
moderately reduced to ;75% to 85%. Four months postoperatively
we found no significant improvement, but 10 years postoperatively
ventilatory function at rest was normalized. Preoperative cardio-
pulmonary exercise capacity was markedly reduced to 50% to 60%;
early postoperatively it was only slightly higher, but late postop-
eratively exercise capacity significantly improved and was com-
pletely normalized.
Conclusions. Although preoperative cardiopulmonary capacity
in adult patients with nonrestrictive ASD was significantly decreased,
some improvement was seen at 4 months postoperatively, with
complete restitution to normal at 10 years after shunt closure.
(J Am Coll Cardiol 1997;29:1345–50)
©1997 by the American College of Cardiology
Patients with atrial septal defect (ASD) are usually asymptom-
atic in early life, but there may be some physical underdevel-
opment and an increased tendency for respiratory infections in
adults (1). Cardiopulmonary symptoms and complications
occur typically in older patients (1,2). Despite significant
volume overloading, many adults with ASD do not complain of
limited exercise capacity (3). However, the operative closure of
defects with significant left to right shunting has been widely
accepted in adults (4–7), although data regarding outcomes in
surgically versus medically treated adult patients in controlled
follow-up studies are lacking. The recently published data of
Konstantinides et al. (8) showed that ASD closure in patients
.40 years old increases long-term survival and limits deterio-
ration of function due to heart failure. The main purpose of
the present study was to examine quantitatively whether ASD
closure is preferrable from the standpoint of exercise toler-
ance. Published follow-up data after closure of an ASD consist
of subjective evaluation of functional classes (6–8) and objec-
tive data, including measurement of respiration and circulatory
function at rest and during exercise are lacking. Ventilatory
function at rest has been reported (9,10) to be normal or
borderline in many patients with uncomplicated ASD in the
first decades of life. Vital capacity and forced expiratory
volume in 1 s at rest decrease but not before pulmonary
resistance increases in progressive stages of the disease (11,12).
The present study was undertaken to determine ventilatory
function at rest and cardiopulmonary exercise capacity preop-
eratively and 4 months and 10 years after defect closure. We
also examined whether cardiorespiratory limitations in patients
with ASD are detectable earlier and more sensitively under
exercise conditions and whether such possible alterations are
reversible postoperatively.
Methods
Patients. We included all patients with ASD closure at our
institution between March 1982 and April 1983 who gave
informed consent to participate in the study. Patients with
additional coronary heart disease, valvular heart disease or
pulmonary disease and those unable to exercise were excluded.
Catheterization of the right heart and pulmonary artery,
including oximetry, was performed in all patients. All patients
.40 years old with a risk constellation underwent coronary
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angiography, and those with coronary heart disease (stenosis
.50%) were excluded from the study cohort, leaving 31
patients for inclusion (15 women, 16 men; mean age 39.9 years,
range 19 to 56). Twenty-seven patients had an ostium secun-
dum defect; three had a sinus venosus defect; and one had an
isolated ostium primum defect. The ratio of pulmonary to
systemic blood flow (Qp/Qs) was 2.8 6 1.2. Mean pulmonary
artery pressure was 18.2 6 6.2 mm Hg, and mean pulmonary
vascular resistance was 0.83 6 0.68 mm Hg 3 min/liter (Table
1). Twenty-nine patients had normal sinus rhythm; one had
atrial fibrillation; and one with sinus venosus defect had an
ectopic atrial focus preoperatively. ASD was diagnosed 2 to 4
months preoperatively, and findings at catheterization were
confirmed in all patients intraoperatively. All operations were
performed with standard cardiopulmonary bypass using bicaval
and ascending aorta cannulation and with moderate hypother-
mia and Bretschneider cardioplegia. The defect was closed by
direct suture, pericardial or Dacron patch. All patients were
reexamined at 4 months postoperatively; at 10 years postoper-
atively, reevaluation of 22 patients was possible (mean age 50.3
years, range 29 to 67; 14 women, 8 men). We could not contact
five of the missing nine patients: Three were from states of the
former Yugoslavia; one declined to appear because of his
excellent condition; and one, who lived relatively far away,
declined to appear because of marked heart failure. The latter
patient (Table 1, Patient 19) had had increased left atrial
pressure at the time of diagnosis of ASD (14 mm Hg; mitral
valve disease was excluded). A report by the patient’s physician
revealed global heart failure. One other patient with known
severe arterial hypertension (postoperative RR values up to
230/120 mm Hg despite intensive medical treatment [Table 1,
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ASD 5 atrial septal defect
FEV1 5 forced expiratory volume in 1 s
Qp/Qs 5 ratio of pulmonary to systemic flow














(mm Hg 3 min/liter)
1/M 49 21 — 16.1 7.1 0.87
2/F 30 18 — 32.0 3.9 0.25
3/F 43 11 4 6.1 4.3 1.16
4/M 48 15 8 11.2 5.1 0.55
5/M 52 20 — 11.7 5.9 1.36
6/M 19 17 11 23.1 5.0 0.26
7/F 44 17 4 7.5 3.5 1.73
8/F 51 19 11 11.7 3.2 0.68
9/F 24 15 6 17.7 4.4 0.34
10/F 19 13 8 16.9 7.4 0.30
11/M 48 15 8 9.3 4.2 0.75
12/M 45 18 5 17.8 6.3 0.73
13/F 42 22 — 14.6 6.2 1.10
14/F 56 14 — 7.7 4.1 1.30
15/M 42 17 10 18.8 7.7 0.37
16/F 51 24 — 10.6 4.4 0.94
17/F 46 13 — 13.9 6.2 0.43
18/F 41 14 — 11.8 4.6 0.51
19/M 50 31 — 19.4 7.3 0.88
20/F 18 13 — 11.1 4.8 0.72
21/F 30 15 9 8.9 3.1 0.45
22/F 28 12 — 12.9 3.5 0.47
23/M 49 22 — 16.1 6.4 0.93
24/F 42 18 — 16.4 3.5 0.85
25/M 37 20 — 16.2 6.5 0.90
26/M 52 17 — 12.4 5.0 0.89
27/M 42 14 11 27.4 6.9 0.11
28/M 19 21 — 28.1 8.9 0.50
29/M 27 14 7 15.7 6.1 0.45
30/F 46 20 — 13.6 6.6 0.95
31/M 48 43 7 9.5 5.4 3.90
Mean 39.93 18.2 7.8 15.0 5.4 0.83
6SD 611.5 66.2 62.3 66.1 61.5 60.68
F 5 female; M 5 male; Pc 5 mean capillary wedge pressure; PPA 5 mean pulmonary artery pressure; PAR 5
pulmonary artery resistance; PBF 5 pulmonary blood flow; Pt 5 patient; SBF 5 systemic blood flow.
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Patient 16]) died 10 days postoperatively; Autopsy of this
patient revealed changes due to brain bleeding. Another
patient died of cancer 7 years postoperatively.
Protocol. Heart catheterization was performed 2 to 4
months preoperatively, and ventilatory function at rest was
determined and a cardiopulmonary exercise test performed 1
to 5 days preoperatively in all patients. Intraoperatively, small
pulmonary biopsy samples were taken; 4 months and 10 years
postoperatively, patients were reexamined by determination of
ventilatory function at rest and a cardiopulmonary exercise test
(routine postoperative examinations of patients were per-
formed by cardiologists in their residential areas). Patients
were not encouraged to engage in fitness programs during the
4-month to 10-year interval after intervention. No specific
fitness activities were reported by the patients at the time of
reexamination. In all cases, a persistent postoperative shunt
could be excluded by echocardiography.
Diagnostic catheterization was performed preoperatively in
all patients, and we measured left atrial, right atrial, pulmonary
artery and pulmonary artery wedge pressures. In addition,
oxygen saturation of the pulmonary artery and superior and
inferior venae cavae was measured. Using these data and
oxygen uptake measured at rest, we calculated pulmonary
and systemic flow and the left to right shunt.
Ventilatory function at rest was determined by a body
plethysmograph at constant pressure (Fa Fenyves & Gut,
Basel, Switzerland). We documented respiratory airway resis-
tance, thoracic gas volume, expiratory reserve volume, residual
volume, vital capacity, total lung capacity, forced expiratory
volume in 1 s (FEV1) and maximal voluntary ventilation.
Values were compared with normal data for age, gender and
body mass (Ru¨hle et al. [13], Amrein et al. [14] and EGKS
European Society of Coal and Steel normal values).
Cardiopulmonary exercise test. Cardiopulmonary exercise
testing was performed with a symptom-limited 1-min incre-
mental work test protocol (computerized cardiopulmonary
exercise test, FA Fenyves & Gut). We used a bicycle ergometer
in the upright position (Bosch ERG 602, Stuttgart, Germany).
The exercise test began with 4 min of unloaded cycling under
steady state conditions at rest before the start of the actual
stress test with increasing 15 W/min. The examination was
performed with an open system. Gas analysis was performed
for oxygen by the paramagnetic principle (Oxytest S, Fa
Hartmann and Braun, Frankfurt am Main, Germany) and for
carbon dioxide by the ultrared absorption method (Uras MZ,
Fa Hartmann and Braun). We measured the following vari-
ables: ventilatory flow, inspiratory–expiratory oxygen concen-
tration difference, expiratory carbon dioxide concentration.
From these variables we calculated on-line the oxygen uptake,
peak oxygen uptake, carbon dioxide delivery, respiratory ratio
and ventilatory equivalents for oxygen and carbon dioxide. The
anaerobic threshold was determined according to the criteria
of Wasserman and colleagues (15,16), especially with regard to
the respiratory equivalent for oxygen (17). We measured
maximal performance and performance at anaerobic threshold
in relation to that in a normal group. Normal values for gender
and age-related oxygen uptake were calculated by the pre-
dicted value of Wasserman et al. (16).
Statistics. Results are presented as mean value 6 SEM.
Data were analyzed by one-way analysis of variance. For
multiple intergroup comparison, the Scheffe´ test was used as a
post hoc test, according to that proposed by Wallenstein et al.
(18) (statistical package JMP, SAS Institut Inc.), and p , 0.05
was regarded significant (p , 0.01 highly significant).
Results
Preoperative variables. Mean pulmonary artery pressure
preoperatively was 18.2 6 6.2 mm Hg, in the upper normal
range. The results of the preoperative heart catheterization are
shown in detail in Table 1. Mean pulmonary wedge pressure
was 7.9 6 2.3 mm Hg; pulmonary blood flow ranged from 6.1
to 32.0 liters/min (mean 15.0 6 5.4 liters/min). Qp/Qs was
2.8 (range 1.4 to 8.2; all patients but three had a Qp/Qs
ratio $2.0). Pulmonary resistance was normal (0.83 6
0.68 mm Hg 3 min/liter).
Events during follow-up. At postoperative reexamination,
there was no evidence for a persistent shunt by echocardiog-
raphy. One patient, who had atrial fibrillation preoperatively,
developed atrial tachycardia postoperatively. One additional
patient developed atrial fibrillation postoperatively. One of the
three patients with sinus venosus defect showed a preoperative
and postoperative ectopic atrial focus with inverted P waves on
leads I, II and aVF. All other patients were in sinus rhythm at
10 years postoperatively. One patient, with markedly reduced
cardiopulmonary exercise capacity 10 years postoperatively,
underwent coronary artery bypass graft surgery with rethora-
cotomy 6 years after ASD closure (this patient was included in
the calculation of mean values).
Ventilatory function at rest. The results of ventilatory
function at rest in a normal group are shown in Figure 1.
Figure 1. Ventilatory function at rest expressed as vital capacity (VC),
forced expiratory volume in 1 s (FEV1), residual volume (RV) and
maximal voluntary ventilation (MVV). Columns 5 mean value 6
SEM. pre-op 5 preoperatively; post-op 5 postoperatively. *p , 0.05.
**p , 0.01.
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Preoperatively the values for vital capacity, FEV1 and maximal
voluntary ventilation were slightly decreased compared with
those in a group of normal subjects (75% to 85%). Residual
volume was increased to ;150%. Ventilatory function at rest
at 4 months postoperatively was not markedly changed in
relation to the preoperative results. At 10 years postopera-
tively, there was a significant change, with normalization of
vital capacity, FEV1 and maximal voluntary ventilation. Resid-
ual volume was significantly decreased compared with the
preoperative value and nearly normalized.
Cardiopulmonary exercise test. The results of the cardio-
pulmonary exercise test are shown in Figures 2 and 3. Cardio-
pulmonary exercise capacity, expressed as exercise capacity at
anaerobic threshold, and maximal exercise capacity and oxygen
uptake at these levels are reduced preoperatively to ;50% to
60%. At 4 months postoperatively, we found no significant
improvement in maximal performance and peak oxygen up-
take or performance and oxygen uptake at anaerobic thresh-
old. At 10 years postoperatively, both values increased signif-
icantly and reached normal values at both levels.
The absolute value for peak oxygen uptake was markedly
decreased to 13.1 ml/kg per kg body weight preoperatively,
tended to increase at 4 months postoperatively to 13.6 ml/kg
per kg body weight and significantly improved to 27.0 ml/kg per
kg body weight at 10 years postoperatively. We found the same
pattern for oxygen uptake at anaerobic threshold: 7.8, 8.5 and
16.1 ml/kg per kg body weight, respectively. Despite the
patients being 10 years older at the late reexamination, exer-
cise capacity even in absolute terms was markedly higher. This
improvement was observed for both maximal performance
(1.64, 1.76 and 2.07 W/kg per kg body weight, respectively) and
performance at anaerobic threshold (0.53, 0.66 and 1.08 W/kg
per kg body weight, respectively).
There was a negative correlation between mean pulmonary
artery pressure and maximal performance (W/kg) (r 5 20.40)
and peak oxygen uptake (ml/kg per min) (r 5 20.43) preop-
eratively. There was no close relation between shunt volume
and cardiopulmonary exercise values.
Pulmonary biopsy samples showed only mild histologic
alteration of the pulmonary arteries with no correlation to
cardiopulmonary exercise test data, and additional pulmonary
diseases were excluded.
Discussion
The results of the present study indicate that in adults with
ASD, left to right shunt .40% of pulmonary blood flow and
absence of pulmonary hypertension, ventilatory function at
rest is only slightly reduced before defect closure; in contrast,
cardiopulmonary exercise capacity is significantly impaired
despite only minor subjective complaints.
Ten years after defect closure, ventilatory function at rest
normalizes, and complete normalization of the preoperatively
limited exercise capacity is possible in the long term.
Ventilatory function. Uncomplicated ASD is well tolerated
long term despite high pulmonary blood flow and right heart
volume overloading (1,2). Reports have documented that a few
patients with an ASD have survived into their 80s (19,20).
Burdzinnska et al. (10) found normal values for vital capacity
and borderline decreased values for FEV1 in children with
ASD. In older patients, the lung volumes become smaller, and
bronchial obstruction develops. Schofield et al. (11) and De
Troyer et al. (12) found in patients with ASD a reduction of
vital capacity and FEV1, with increasing pulmonary artery
pressure. With increasing pulmonary artery pressure, De
Troyer et al. found an increasing pulmonary airway resistance.
A possible explanation for this increasing pulmonary airway
resistance is the high pulmonary blood volume (21). Hogg et al.
(22) hypothesized that there is competition between the in-
trapulmonary blood vessels and the small airways for space,
and the expansion of the small pulmonary vessels causes a
narrowing of the bronchiole and an increase in airway resis-
tance. Their data are in accordance with those of the present
study, with pulmonary artery pressure in the upper normal
range preoperatively and slightly reduced values for vital
capacity and FEV1 in parallel. The high residual volume may
Figure 2. Cardiopulmonary exercise capacity at anaerobic threshold
(AT) levels. Columns 5 mean value 6 SEM. Abbreviations as in
Figure 1. *p , 0.01.
Figure 3. Maximal cardiopulmonary exercise capacity expressed as
peak oxygen uptake and performance in relation to normal subjects.
Columns 5 mean value 6 SEM. Abbreviations as in Figure 1. *p ,
0.05. **p , 0.01.
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be explained by the increased airway resistance of 130%.
However, the hypothesis of increased intrapulmonary blood
vessel volume being the main reason for the increased resis-
tance and residual volume might be challenged by the persis-
tently increased resistance 4 months postoperatively despite
successful defect closure.
Four months after defect closure, ventilatory function at
rest did not change markedly. This lack of improvement early
after defect closure may be explained by the trauma of
operation. According to our data, Nolte (23) reported an
impaired vital capacity of 30% in patients 14 days after
thoracotomy, and Uhl (24) found that 6 to 8 weeks after
thoracotomy, vital capacity decreased by ;10% (24). Ten years
after defect closure, the values for ventilatory function at rest
normalized in our study group, probably because of the missing
pulmonary vessel overloading postoperatively and only mild
histologic alteration of the pulmonary arteries.
Exercise capacity. In contrast to the only slightly reduced
ventilatory function at rest in our group of patients with
pulmonary artery pressure in the upper normal range, cardio-
pulmonary exercise capacity was significantly impaired despite
only minor subjective complaints. The complaints of the
patients are difficult to quantify in this group with significant
left to right shunt but no pulmonary hypertension. Although
they often denied relevant exercise limitations or had disabling
symptoms only according to functional class II preoperatively,
they reported improvement in exercise capacity at 10 years
after defect closure; they could not have known preoperatively
how well they would feel postoperatively because they had
adapted to their condition. Sutton et al. (5) reported that
;60% of their patients were in functional class III or IV, but
they examined patients $60 years old, and pulmonary artery
pressure was markedly higher in their patients than in ours.
Most studies agree that the presence and severity of func-
tional limitation among patients with ASD increases with age.
Hamilton et al. (2) found that only 4% of their patients .40
years old were asymptomatic as opposed to 71% in the first
decade of life (2). Markman et al. reported that 6% of their
patients at the end of the fourth decade were in functional class
III or IV, rising to 30% by the end of the fifth decade and to
49% by the sixth decade (1). These and other studies (4–6) are
based on data influenced by subjective complaints of the
patients and, because they were made before the “era of
echocardiography,” often represent the “bad end of the spec-
trum,” with the resultant problem of an obvious bias. However,
from this “early era” the report of Murphy et al. (25) should be
mentioned, in which long-term follow-up data of patients with
ASD who had been treated surgically were compared with that
from an age- and gender-matched control group without ASD.
They reported that the overall survival of the surgically treated
patients was better than that among medically treated controls.
The present study showed by objective measurement a
decreased cardiopulmonary exercise capacity to ;50% to 60%,
expressed by performance (W/kg) and oxygen uptake. Many
young study patients with a relative lack of symptoms had
objectively decreased exercise tolerance. Cardiopulmonary ex-
ercise testing is recognized as an objective means of assessing
functional capacity in patients with chronic heart failure
(16,26,27). Determination of anaerobic threshold and oxygen
uptake and performance at this level represents an important
aspect of exercise function that is particularly relevant to the
exercise tolerance of patients with cardiac disease.
Four months postoperatively, cardiopulmonary exercise
capacity in our study group increased somewhat, but there was
no significant improvement. This result may be explained by
the trauma of operation and the lack of a training effect.
Normalization of cardiopulmonary exercise capacity, ex-
pressed by all four variables (peak oxygen uptake, oxygen
uptake at anaerobic threshold, maximal performance and
performance at anaerobic threshold) was documented 10 years
after defect closure, but it is probable that this improvement
took place much earlier. The data assessed by questionnaire in
the referring physicians or directly in the patients to determine
functional class suggest that the improvement in the exercise
capacity takes place after 1 to 2 years. Because of missing
exercise tests we do not have quantitative results, and the exact
time is not clear. However, long-term improvement seems to
be much more important and quantitatively underscores the
findings of Konstantinides et al. (8). Normalization of exercise
capacity confirms the data of other investigators who report
that most of their patients were symptomatically improved by
at least one functional class postoperatively (5,7). In contrast,
Shah et al. (3) found no improvement in the functional class
after defect closure (3); however, their study group differed in
that .70% of their patients were symptom free, so that no
improvement could be shown. Seventy-one percent of their
surgically treated patients were in functional class I and 29% in
class II preoperatively, and only a few patients went from class
I to class II at late reevaluation. Shah et al. did not find any
benefit from operative treatment with respect to mortality,
atrial fibrillation, emboli and incidence of breathlessness and
cardiac failure. However, as Ward (28) discussed, the study by
Shah et al. (3) was not a controlled study, and the indications
for inclusion in medical or surgical groups are not clear; and by
design, patients with advanced pulmonary vascular disease
were not enrolled. Murphy et al. (25) reported that the overall
survival of the surgically treated patients was better than that
among medically treated historical control subjects (1,29–32).
They found that closure of an ASD in patients $24 years old
was associated with normal long-term survival. Closure in
patients 25 to 41 years old was associated with good long-term
survival but shorter than that expected in a normal population,
and closure after 41 years of age was associated with signifi-
cantly increased late mortality. Konstantinides et al. (8) re-
sponded to the question of whether patients .40 years old
benefit from defect closure. In 1995 they published a compar-
ison of surgical and medical therapy for ASD closure in adults
and found that surgical repair in patients .40 years old
increases long-term survival and limits the deterioration of
function caused by heart failure. The risk of atrial arrhythmia
was not reduced by closure of the defect. A limitation of the
study of Konstantinides et al. was the retrospective, nonran-
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domized assignment of patients to the two treatment groups
and the subjectively influenced functional classes; but the
differences in the surgically treated group versus the medically
treated patients did not indicate a more favorable prognosis
for one group, especially with regarding to age, pulmonary
artery resistance and Qp/Qs ratio. According to these data,
Sutton et al. (5) also found an improvement in functional class
in his patients .60 years old. We did not find such age-related
results for cardiopulmonary exercise capacity, but our group
was probably too small to see such differences in age sub-
classes. The mortality and morbidity rates in this small cohort
are not representative enough to calculate statistics (the mor-
tality rate at our center was #0.05% in the past decade),
especially when taking into account the fact that the patient
who died early postoperatively and the patient with global
heart failure had severe concomitant disease.
Conclusions. From the findings of the present and previous
studies, it can be concluded that even if older patients with
ASD do not have a normal life expectancy after defect closure,
surgical treatment is superior to medical treatment with regard
long-term survival and prevention of functional limitations due
to heart failure, and cardiopulmonary exercise capacity can be
improved in these patients over the long term. Cardiopulmo-
nary exercise testing is a feasible and important method for
detecting functional impairment before defect closure. Adults
with markedly reduced exercise tolerance often have few
subjective complaints, and the finding of significant postoper-
ative improvement may be helpful in making decisions with
respect to operative management.
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